Short Term Weakness to Stay

NASDAQ:GOVX   GeoVax Labs, Inc
Still a keeper. The selling can continue but would be adding on intervals. $7.25 is the first target and could retest ATH eventually.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.